M Kurtz Biography and Net Worth

CEO of RxSight

Dr. Kurtz has served as our President and Chief Executive Officer, as well as on our board since 2016. Prior to joining RxSight, he co-founded and served as President and Chief Executive Officer of LenSx Lasers, Inc. He became General Manager of Alcon LenSx, Inc after the company was acquired by Alcon Inc. (NYSE:ALC) in 2010. Dr. Kurtz previously co-founded IntraLase Corp. (NASDAQ:ILSE) serving as its initial President & CEO and then in other senior leadership positions. IntraLase became a publicly held NASDAQ-listed company in 2004 and was acquired by Advanced Medical Optics, Inc. (NYSE:AMO) in 2007. Dr. Kurtz has served on the faculty of both the University of California, Irvine, and the University of Michigan. He earned his B.A. in Biochemistry from Harvard College and his M.D. from the University of California, San Diego.

What is M Md Kurtz's net worth?: The estimated net worth of M Md Kurtz is at least $10.77 million as of May 3rd, 2024. Kurtz owns 764,610 shares of RxSight stock worth more than $10,765,709 as of April 13th. This net worth estimate does not reflect any other assets that Kurtz may own. Additionally, Kurtz receives an annual salary of $1,210,000.00 as CEO at RxSight. Learn More about M Md Kurtz's net worth.
How old is M Md Kurtz?: Kurtz is currently 61 years old. There are 3 older executives and no younger executives at RxSight. Learn More on M Md Kurtz's age.
What is M Md Kurtz's salary?: As the CEO of RxSight, Inc., Kurtz earns $1,210,000.00 per year. Learn More on M Md Kurtz's salary.
How do I contact M Md Kurtz?: The corporate mailing address for Kurtz and other RxSight executives is , , . RxSight can also be reached via phone at 949-521-7830 and via email at ir@rxsight.com. Learn More on M Md Kurtz's contact information.
Has M Md Kurtz been buying or selling shares of RxSight?: M Md Kurtz has not been actively trading shares of RxSight during the last ninety days. Most recently, Ronald M. Md Kurtz sold 40,000 shares of the business's stock in a transaction on Friday, May 3rd. The shares were sold at an average price of $60.15, for a transaction totalling $2,406,000.00. Following the completion of the sale, the chief executive officer now directly owns 764,610 shares of the company's stock, valued at $45,991,291.50. Learn More on M Md Kurtz's trading history.
Who are RxSight's active insiders?: RxSight's insider roster includes Julie Andrews (Director), Juliet Bakker (Director), Jesse Corley (Director), Tamara Fountain (Director), Ilya Goldshleger (Insider), Ilya Goldshleger (Insider), M Kurtz (CEO), William Link (Director), Shweta Maniar (Director), Shelley Thunen (CFO), Robert Warner (Director), and Eric Weinberg (Insider). Learn More on RxSight's active insiders.
Are insiders buying or selling shares of RxSight?: In the last year, RxSight insiders bought shares 2 times. They purchased a total of 12,554 shares worth more than $549,098.81. In the last year, insiders at the sold shares 28 times. They sold a total of 160,951 shares worth more than $8,269,376.44. The most recent insider tranaction occured on March, 12th when Director Tamara Fountain sold 7,000 shares worth more than $179,970.00. Insiders at RxSight own 9.4% of the company. Learn More about insider trades at RxSight.
Information on this page was last updated on 3/12/2025.

M Md Kurtz Insider Trading History at RxSight

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/3/2024	Sell	40,000	$60.15	$2,406,000.00	764,610
1/8/2024	Sell	62,500	$44.25	$2,765,625.00	804,610
12/27/2023	Sell	22,500	$41.09	$924,525.00	867,110
12/14/2023	Sell	40,000	$39.70	$1,588,000.00	889,610

M Md Kurtz Buying and Selling Activity at RxSight

RxSight Company Overview

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Today's Range

Now: $14.08

$13.50

$14.56

50 Day Range

MA: $25.63

$14.08

$34.26

2 Week Range

Now: $14.08

$13.50

$66.54

Volume

1,102,327 shs

Average Volume

605,044 shs

Market Capitalization

$570.11 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.26

M Kurtz Biography and Net Worth

What is M Md Kurtz's net worth?

How old is M Md Kurtz?

What is M Md Kurtz's salary?

How do I contact M Md Kurtz?

Has M Md Kurtz been buying or selling shares of RxSight?

Who are RxSight's active insiders?

Are insiders buying or selling shares of RxSight?